Health Net
Kanjinti (Intravenous Solr) (Trastuzumab-Pkrb)
Drugs for Cancer : Drugs for Cancer
  • Step Therapy: Cystic Fibrosis (CF):
    ST Multiple Generics

  • Prior Authorization: PA Required
  • Colorectal Cancer:
    Duration: 1 year(s)
    Documented Diagnosis Requirement: Inferred from Available Documentation
    Medical Test Required: Yes
    Reauthorization Required: No
    Duration of Reauthorization: N/A
    Drug Policy Based On: NCCN Guidelines
    Documented Diagnosis: Yes
    Specialty Pharmacy is Required: Not Defined